1 FINANCIAL DISCLOSURES AND CONFLICTS OF INTEREST IN CLINICAL RESEARCH Richard S Liner, JD Ronald H. Clark, PhD, JD Arent Fox Kintner Plotkin & Kahn, PLLC.
What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
Guidance on 1572
Research with Adults with Diminished Capacity to Provide Consent Susan Loess-Perez, MS, CIP, CCRC Director, Office of Research Protections DePaul University.
IRB ORIENTATION New Member Helen Panageas, CIP Associate Director NYU School of Medicine INSTITUTIONAL REVIEW BOARD Kim Diccianni, CIP Investigator Liaison.
MANAGING CONFLICTS OF INTEREST IN UM/JHS HUMAN SUBJECT RESEARCH 1.GENERAL PRINCIPALS AND PROCEDURES 2. REGULATIONS, POLICIES AND UM PROCESS Human Subjects.
Welcome to the IRB. IRB ORIENTATION New Member Helen Panageas, CIP Associate Director NYU School of Medicine INSTITUTIONAL REVIEW BOARD .
Protection Regulations Human Subjects Research
pre pre pre
